Additional work will be necessary to understand the functional mechanisms underlying STEAP1 antigen loss and more generally how dynamic effects of adoptive CAR T cell therapy may contribute to antigen loss and immunoediting by modulating tumor-immune-stromal interactions in solid tumors. Here, STEAP1 is linked to neoplasm.